as on December 31, 2025 at 2:28 am IST
Day's Low
Day's High
0.35%
Downside
8.97%
Upside
52 Week's Low
52 Week's High
29.49%
Downside
252.56%
Upside
Check Metavia Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$21.2M
EPS (TTM)
-9.2125
Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
-168.18%
Compare market cap, revenue, PE, and other key metrics of Metavia Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $21.2M | NA | NA | 0.00% | |
| BUY | $37.6B | 418.95% | -16.34 | -264.83% | |
| BUY | $52.9B | 204.35% | 1430.68 | 1.36% | |
| BUY | $118.7B | 97.6% | 32.58 | 31.35% | |
| BUY | $83.2B | 63.18% | 18.83 | 32.13% |
The Metavia Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Metavia Inc investment value today
Current value as on today
₹44,348
Returns
Returns from Metavia Inc Stock
Dollar Returns*
₹4,954 (+4.95%)
Search interest for Metavia Inc Stock has increased by 23% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:23% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 156.0% return, outperforming this stock by 214.7%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 782.6% return, outperforming this stock by 725.8%
Price Dip
![]()
In the last 7 days, MTVA stock has moved down by -6.2%
| Organisation | Metavia Inc |
| Headquarters | 545 Concord Avenue, Cambridge, MA, United States, 02138 |
| CEO | Mr. Heon Kim Hyung |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Robert Homolka | Senior Vice President of Clinical Operations |
Dr. W. Christopher Fang M.D. | Consulting Chief Medical Officer & Advisor |
Mr. Michael C. Pine | Senior Vice President of Business Development Advisor |
Mr. Heon Kim Hyung | CEO, President & Director |
Mr. Marshall H. Woodworth | Chief Financial Officer |
Dr. Mi-Kyung Kim | Chief Scientific Officer |
Metavia Inc share price today is $8.58 as on at the close of the market. Metavia Inc share today touched a day high of $9.35 and a low of $8.55.
Metavia Inc share touched a 52 week high of $30.25 on and a 52 week low of $6.05 on . Metavia Inc stock price today i.e. is closed at $8.58,which is 71.64% down from its 52 week high and 41.82% up from its 52 week low.
Metavia Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Metavia Inc (MTVA) shares with as little as ₹89.737 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹897.37 in Metavia Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Metavia Inc share’s latest price of $8.58 as on December 31, 2025 at 2:28 am IST, you will get 1.1655 shares of Metavia Inc. Learn more about
fractional shares .